<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335635">
  <stage>Registered</stage>
  <submitdate>23/06/2010</submitdate>
  <approvaldate>30/06/2010</approvaldate>
  <actrnumber>ACTRN12610000532000</actrnumber>
  <trial_identification>
    <studytitle>Garlic and Candida: A Pilot study (PAThWAY)</studytitle>
    <scientifictitle>A randomised controlled pilot study comparing the effect of oral garlic tablets compared to oral placebo tablets on vaginal colonisation with Candida in women of childbearing age with a history of vulvovaginal candidiasis</scientifictitle>
    <utrn>U1111-1115-5431</utrn>
    <trialacronym>PAThWAY: Potential Alternative Therapy: Women, Allicin, Yeast</trialacronym>
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Vulvovaginal candidiasis</healthcondition>
    <conditioncode>
      <conditioncode1>Alternative and complementary medicine</conditioncode1>
      <conditioncode2>Herbal remedies</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Skin</conditioncode1>
      <conditioncode2>Dermatological conditions</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Infection</conditioncode1>
      <conditioncode2>Other infectious diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Two garlic tablets twice a day after food for 14 days
(garlic powder bulb 350mg X 2 for a daily total dose of 1400mg 4 tablets)</interventions>
    <comparator>Two lactose placebo tablets twice a day after food for 14 days</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Other</interventioncode>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Vaginal colonisation with Candida in intervention and control groups using self collected vaginal swabs for the 14 days of the study</outcome>
      <timepoint>Daily colony counts of Candida from day 14-28 of the menstrual cycle for one menstrual cycle only</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Colonisation patterns of Candida throughout the menstrual cycle</outcome>
      <timepoint>Daily colony counts over the luteal phase of one menstrual cycle for each participant</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>18-50 years, of reproductive age
Previous history of vulvovaginal candidiasis (VVC)
Asymptomatic for vaginitis (i.e. no abnormal vaginal discharge or itchiness)
Able to take two vaginal swabs and post them daily for approximately 14 days
Able and willing to take 2 herbal tablets twice a day for approximately 14 days
Agree not to self medicate with over the counter medications, herbal or complementary medicines, and abstain from added garlic in diet for the duration of the study</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>50</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Bleeding disorders / taking warfarin / peptic ulcers
Intended surgery during or immediately after the study period
Pregnant or breastfeeding</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Participants respond to advertisement. Determination whether they are eligible with direct communication with participant. Eligible women sent plain language statement, consent form and entry questionnaire. Once enrolled, given study number in order of enrolment.

Randomisation schedule devised by statistician at Dept of General Practice, University of Melbourne. This schedule given directly to pharmacist at Royal Women's Hospital, who allocates placebo/intervention according to schedule. No researchers are given the randomisation schedule and are unaware of the group in which the eligible participant is allocated. The containers are then sealed and given to researcher for distribution in order of enrolment.</concealment>
    <sequence>Randomisation schedule is devised by statistician at Dept of General Practice, University of Melbourne using a simple randomisation table created by computer software (computorised sequence generation).</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 0</phase>
    <anticipatedstartdate>2/06/2010</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>10</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Melbourne</primarysponsorname>
    <primarysponsoraddress>Department of General Practice
200 Berkeley St
Carlton 3053 VICTORIA</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Shepherd Foundation</fundingname>
      <fundingaddress>Suite 33, Cabrini Medical Centre, MALVERN  VIC  3144</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>Royal Melbourne Institute of Technology (RMIT)</sponsorname>
      <sponsoraddress>RMIT University Building 223, Level 1, Bundoora Campus Plenty Road, Bundoora, 3083 Victoria</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study is a pilot study to take place prior to a larger Randomised Controlled Trial (RCT) "Garlic and Candida: An Exploratory Study." The RCT proposes to investigate the biological plausibility of oral garlic reducing recurrences of vaginal thrush by reducing the vaginal colonisation of Candida albicans.

The RCT will involve women taking either oral daily garlic tablets or placebo, keeping a daily diary, and self collecting daily vaginal swabs and posting them to the laboratory  during the second half of their menstrual cycle. This pilot study will evaluate the methodology  by assessing the tolerability of the garlic tablets, the postage of the swabs, and the daily diary. It will also include a validation study on postage of vaginal swabs.</summary>
    <trialwebsite>none</trialwebsite>
    <publication>none</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Human Research Ethics Committee (HREC) University of Melbourne</ethicname>
      <ethicaddress>Melbourne Research Office
University of Melbourne
Victoria 3010</ethicaddress>
      <ethicapprovaldate>13/05/2010</ethicapprovaldate>
      <hrec>0933026</hrec>
      <ethicsubmitdate>17/02/2010</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Cathy Watson</name>
      <address>Department of General Practice
University of Melbourne
200 Berkeley St
Carlton 3103
Victoria</address>
      <phone>+61 3 9035 5685</phone>
      <fax>+61 3 9347 6136</fax>
      <email>cathyw@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Cathy Watson</name>
      <address>Department of General Practice
University of Melbourne
200 Berkeley St
Carlton 3103
Victoria</address>
      <phone>+61 3 9035 5685</phone>
      <fax>+61 3 9347 6136</fax>
      <email>cathyw@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Cathy Watson</name>
      <address>Department of General Practice
University of Melbourne
200 Berkeley St
Carlton 3103
Victoria</address>
      <phone>+61 3 9035 5685</phone>
      <fax>+61 3 9347 6136</fax>
      <email>cathyw@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>